 Drug infusion will be discontinued if any of the following adverse events are observed: recurrent apnea Respiratory Rate 7 lasting more than 30 seconds over a 5 min observation period, sustained episodes 30 seconds hemoglobin oxygen saturation lower than 90 over a 5 min observation period, decrease of heart rate to below 50 beatsmin, mean arterial pressure below 70 of its initial value. 